Click for best price
Chimeric Antigen Receptor CAR TCell Immunotherapy Market Size, Share 2023
The basic principle of chimeric antigen receptor T cell immunotherapy is to use the patient?s own immune cells to eliminate cancer cells. Among them, chimeric antigen receptor (CAR) is the core component of CAR-T, giving T cells HLA-independent recognition The ability of tumor antigens, which enables CAR-modified T cells to recognize a wider range of targets than the natural T cell surface receptor TCR. The basic design of CAR includes a tumor-associated antigen (TAA) binding region (usually derived from the scFV segment of the monoclonal antibody antigen binding region), an extracellular hinge region, a transmembrane region and an intracellular signal Area
This report aims to provide a comprehensive presentation of the global market for Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy. This report contains market size and forecasts of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy in global, including the following market information:
Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Allogeneic CAR T-Cells Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy include Pfizer, Novartis, Bristol Myers Squibb, Legend Biotech, Sorrento Therapeutics, CARSGEN Therapeutics?Ltd, Juno Therapeutics, Kite Pharma and Atara Biotherapeutics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Segment Percentages, by Type, 2022 (%)
Allogeneic CAR T-Cells
Autologous CAR T-Cells
Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Segment Percentages, by Application, 2022 (%)
Hospital
Diagnostic Center
Others
Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Novartis
Bristol Myers Squibb
Legend Biotech
Sorrento Therapeutics
CARSGEN Therapeutics?Ltd
Juno Therapeutics
Kite Pharma
Atara Biotherapeutics
Carina Biotech
Guangzhou Xiangxue Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy, market overview.
Chapter 2: Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market size in revenue.
Chapter 3: Detailed analysis of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market, Global Outlook and Forecast 2023-2032 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
67 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Overall Market Size
2.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size: 2022 VS 2032
2.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Players in Global Market
3.2 Top Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Companies Ranked by Revenue
3.3 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Companies
3.4 Top 3 and Top 5 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Players in Global Market
3.6.1 List of Global Tier 1 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Markets, 2022 & 2032
4.1.2 Allogeneic CAR T-Cells
4.1.3 Autologous CAR T-Cells
4.2 By Type - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue & Forecasts
4.2.1 By Type - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, 2018-2023
4.2.2 By Type - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, 2024-2032
4.2.3 By Type - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2022 & 2032
5.1.2 Hospital
5.1.3 Diagnostic Center
5.1.4 Others
5.2 By Application - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue & Forecasts
5.2.1 By Application - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, 2018-2023
5.2.2 By Application - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, 2024-2032
5.2.3 By Application - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2022 & 2032
6.2 By Region - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue & Forecasts
6.2.1 By Region - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, 2018-2023
6.2.2 By Region - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, 2024-2032
6.2.3 By Region - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, 2018-2032
6.3.2 US Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.3.3 Canada Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.3.4 Mexico Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, 2018-2032
6.4.2 Germany Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.4.3 France Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.4.4 U.K. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.4.5 Italy Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.4.6 Russia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.4.7 Nordic Countries Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.4.8 Benelux Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, 2018-2032
6.5.2 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.5.3 Japan Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.5.4 South Korea Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.5.5 Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.5.6 India Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, 2018-2032
6.6.2 Brazil Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.6.3 Argentina Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, 2018-2032
6.7.2 Turkey Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.7.3 Israel Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.7.4 Saudi Arabia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
6.7.5 UAE Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, 2018-2032
7 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Major Product Offerings
7.1.4 Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Major Product Offerings
7.2.4 Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue in Global Market (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Bristol Myers Squibb
7.3.1 Bristol Myers Squibb Company Summary
7.3.2 Bristol Myers Squibb Business Overview
7.3.3 Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Major Product Offerings
7.3.4 Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue in Global Market (2018-2023)
7.3.5 Bristol Myers Squibb Key News & Latest Developments
7.4 Legend Biotech
7.4.1 Legend Biotech Company Summary
7.4.2 Legend Biotech Business Overview
7.4.3 Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Major Product Offerings
7.4.4 Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue in Global Market (2018-2023)
7.4.5 Legend Biotech Key News & Latest Developments
7.5 Sorrento Therapeutics
7.5.1 Sorrento Therapeutics Company Summary
7.5.2 Sorrento Therapeutics Business Overview
7.5.3 Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Major Product Offerings
7.5.4 Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue in Global Market (2018-2023)
7.5.5 Sorrento Therapeutics Key News & Latest Developments
7.6 CARSGEN Therapeutics?Ltd
7.6.1 CARSGEN Therapeutics?Ltd Company Summary
7.6.2 CARSGEN Therapeutics?Ltd Business Overview
7.6.3 CARSGEN Therapeutics?Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Major Product Offerings
7.6.4 CARSGEN Therapeutics?Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue in Global Market (2018-2023)
7.6.5 CARSGEN Therapeutics?Ltd Key News & Latest Developments
7.7 Juno Therapeutics
7.7.1 Juno Therapeutics Company Summary
7.7.2 Juno Therapeutics Business Overview
7.7.3 Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Major Product Offerings
7.7.4 Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue in Global Market (2018-2023)
7.7.5 Juno Therapeutics Key News & Latest Developments
7.8 Kite Pharma
7.8.1 Kite Pharma Company Summary
7.8.2 Kite Pharma Business Overview
7.8.3 Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Major Product Offerings
7.8.4 Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue in Global Market (2018-2023)
7.8.5 Kite Pharma Key News & Latest Developments
7.9 Atara Biotherapeutics
7.9.1 Atara Biotherapeutics Company Summary
7.9.2 Atara Biotherapeutics Business Overview
7.9.3 Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Major Product Offerings
7.9.4 Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue in Global Market (2018-2023)
7.9.5 Atara Biotherapeutics Key News & Latest Developments
7.10 Carina Biotech
7.10.1 Carina Biotech Company Summary
7.10.2 Carina Biotech Business Overview
7.10.3 Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Major Product Offerings
7.10.4 Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue in Global Market (2018-2023)
7.10.5 Carina Biotech Key News & Latest Developments
7.11 Guangzhou Xiangxue Pharmaceutical
7.11.1 Guangzhou Xiangxue Pharmaceutical Company Summary
7.11.2 Guangzhou Xiangxue Pharmaceutical Business Overview
7.11.3 Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Major Product Offerings
7.11.4 Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue in Global Market (2018-2023)
7.11.5 Guangzhou Xiangxue Pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Opportunities & Trends in Global Market
Table 2. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Drivers in Global Market
Table 3. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Restraints in Global Market
Table 4. Key Players of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy in Global Market
Table 5. Top Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Type
Table 9. List of Global Tier 1 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, (US$, Mn), 2024-2032
Table 30. Pfizer Company Summary
Table 31. Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offerings
Table 32. Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Novartis Company Summary
Table 35. Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offerings
Table 36. Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 37. Novartis Key News & Latest Developments
Table 38. Bristol Myers Squibb Company Summary
Table 39. Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offerings
Table 40. Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 41. Bristol Myers Squibb Key News & Latest Developments
Table 42. Legend Biotech Company Summary
Table 43. Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offerings
Table 44. Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 45. Legend Biotech Key News & Latest Developments
Table 46. Sorrento Therapeutics Company Summary
Table 47. Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offerings
Table 48. Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 49. Sorrento Therapeutics Key News & Latest Developments
Table 50. CARSGEN Therapeutics?Ltd Company Summary
Table 51. CARSGEN Therapeutics?Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offerings
Table 52. CARSGEN Therapeutics?Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 53. CARSGEN Therapeutics?Ltd Key News & Latest Developments
Table 54. Juno Therapeutics Company Summary
Table 55. Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offerings
Table 56. Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 57. Juno Therapeutics Key News & Latest Developments
Table 58. Kite Pharma Company Summary
Table 59. Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offerings
Table 60. Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 61. Kite Pharma Key News & Latest Developments
Table 62. Atara Biotherapeutics Company Summary
Table 63. Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offerings
Table 64. Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 65. Atara Biotherapeutics Key News & Latest Developments
Table 66. Carina Biotech Company Summary
Table 67. Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offerings
Table 68. Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 69. Carina Biotech Key News & Latest Developments
Table 70. Guangzhou Xiangxue Pharmaceutical Company Summary
Table 71. Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Offerings
Table 72. Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 73. Guangzhou Xiangxue Pharmaceutical Key News & Latest Developments
List of Figures
Figure 1. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Segment by Type in 2022
Figure 2. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Segment by Application in 2022
Figure 3. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue in 2022
Figure 8. By Type - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share, 2018-2032
Figure 9. By Application - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share, 2018-2032
Figure 10. By Type - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share, 2018-2032
Figure 12. By Application - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share, 2018-2032
Figure 14. By Region - Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share, 2018-2032
Figure 15. By Country - North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share, 2018-2032
Figure 16. US Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share, 2018-2032
Figure 20. Germany Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 21. France Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share, 2018-2032
Figure 28. China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 32. India Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share, 2018-2032
Figure 34. Brazil Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share, 2018-2032
Figure 37. Turkey Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 41. Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. CARSGEN Therapeutics?Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
